Status:
COMPLETED
Does PAI Reduce Pain After TKA Among Knee Arthroplasty Patients Receiving ACB & IPACK?
Lead Sponsor:
Hospital for Special Surgery, New York
Conditions:
Total Knee Athroplasty
Eligibility:
All Genders
25-80 years
Phase:
PHASE4
Brief Summary
The goal of this clinical trial is to determine whether Periarticular Injection (PAI) alongside Adductor Canal Block (ACB) and Infiltration between the Popliteal Artery and Capsule of the Knee (IPACK)...
Detailed Description
Kim et al (2019) have shown that addition of ACB/IPACK to PAI improves analgesic outcomes (the nerve blocks reduced pain with ambulation and reduced opioid consumption). TKA patients receiving PAI + A...
Eligibility Criteria
Inclusion
- Planned use of regional anesthesia
- Ability to follow the major components of the study protocol
- English speaking (Secondary outcomes include questionnaires validated in English only)
Exclusion
- Patients younger than 25 years old and older than 80
- Non-English speaking
- Patients intending to receive general anesthesia
- Contraindication to nerve blocks or peri-articular injection
- Patients with an ASA of IV or higher
- Renal insufficiency (ESRD, HD, estimated creatinine clearance \< 30 ml/min)
- Patients with major prior ipsilateral open knee surgery
- Chronic gabapentin/pregabalin use (regular use for longer than 3 months)
- Chronic opioid use (taking opioids for longer than 3 months)
Key Trial Info
Start Date :
December 17 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2022
Estimated Enrollment :
94 Patients enrolled
Trial Details
Trial ID
NCT04749615
Start Date
December 17 2020
End Date
July 1 2022
Last Update
December 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital for Special Surgery
New York, New York, United States, 10021